首页> 外文会议>International symposium on controlled release of bioactive materials >Application of universal hydrophilic matrix (UHM) for transdermal drug delivery systems (TDDS) containing nonsteroidal antiinflamatory drug (NSAID) diclofenac or its salts.
【24h】

Application of universal hydrophilic matrix (UHM) for transdermal drug delivery systems (TDDS) containing nonsteroidal antiinflamatory drug (NSAID) diclofenac or its salts.

机译:通用亲水基质(UHM)对透皮药物递送系统(TDDS)含有非甾体抗性药物(NSAID)双氯芬酸或其盐的应用。

获取原文

摘要

UHM was developed by some of us (1). It has been used in the design of about ten TDDS. Some of them is now registered in Russia (2) as drugs. UHM may be used for the preparation of TDDS involving drugs of very different chemical structure. Many NSAIDs are acids or their salts. In the previous communication (3) we described Indomethacin - containing TDDS, and now we report the design of TDDSs involving most popular NSAID -Diclofenac in acidic or salt form. In ointments the drug may used to short-term treatment, but it is not optimal for long-term treatment or chronic diseases such as artritis.
机译:UHM由我们中的一些人开发(1)。它已被用于约十个TDDS的设计。其中一些人现在在俄罗斯(2)中注册为毒品。 UHM可用于制备涉及具有截然不同化学结构的药物的TDD。许多NSAID是酸还是盐。在以前的通信(3)中,我们描述了含有含有TDD的吲哚美辛,现在我们报告了涉及酸性或盐形式最受欢迎的NSAID -DICLOFENAC的TDDSS的设计。在软膏中,药物可能用于短期治疗,但对于长期治疗或慢性疾病如镉炎并不是最佳的。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号